2 METHODS OF ASSESSMENT OF METHOTREXATE HEPATOTOXICITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:12
|
作者
HALL, PD
AHERN, MJ
JARVIS, LR
STOLL, P
JENNER, MA
HARLEY, H
机构
[1] REPATRIAT GEN HOSP,DEPT MED,ADELAIDE,AUSTRALIA
[2] FLINDERS UNIV,DEPT MED,BEDFORD PK,SA 5042,AUSTRALIA
关键词
D O I
10.1136/ard.50.7.471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serial liver biopsy specimens from 18 patients with rheumatoid arthritis receiving a weekly dose of methotrexate 7.5-20 mg for a minimum of 12 months were assessed semi-quantitatively and by a microcomputer image analysis system. The semiquantitative histological method showed a significant increase in pericellular collagen and in overall disease while morphometry showed a significant increase in pericellular, perivenular, and portal tract collagen. There was a significant correlation between the two methods, but morphometry had the advantage of objectivity and efficiency. There was no correlation between the increase in collagen and the accumulated dose of methotrexate, which suggests that other factors in addition to methotrexate may contribute to liver injury.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 50 条
  • [1] COMPARISON OF METHODS FOR IDENTIFYING EARLY METHOTREXATE-INDUCED HEPATOTOXICITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    ARIA, JM
    MORTON, KA
    ALBRO, JE
    PATCH, GG
    VALDIVIA, S
    GREENBERG, HE
    CHRISTIAN, PE
    DATZ, FL
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (11) : 1905 - 1909
  • [2] HEPATOTOXICITY OF PROLONGED METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS
    MACKENZIE, AH
    CLEVELAND CLINIC QUARTERLY, 1985, 52 (02): : 129 - 135
  • [3] METHOTREXATE-ASSOCIATED HEPATOTOXICITY - RETROSPECTIVE ANALYSIS OF 210 PATIENTS WITH RHEUMATOID-ARTHRITIS
    SHERGY, WJ
    POLISSON, RP
    CALDWELL, DS
    RICE, JR
    PISETSKY, DS
    ALLEN, NB
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (06): : 771 - 774
  • [4] PROSPECTIVE-STUDY OF HEPATOTOXICITY IN PATIENTS RECEIVING METHOTREXATE FOR RHEUMATOID-ARTHRITIS - AN UPDATE
    AUGUR, NA
    ANDERSON, LG
    KEROACK, B
    MILLER, M
    MORTON, GL
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S77 - S77
  • [5] METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SINNETT, MJ
    GROFF, GD
    RADDATZ, DA
    FRANCK, WA
    BERTINO, JS
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (06) : 745 - 748
  • [6] METHOTREXATE IN OLDER PATIENTS WITH RHEUMATOID-ARTHRITIS
    POOLE, P
    YEOMAN, S
    CAUGHEY, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (12): : 860 - 860
  • [7] CHLOROQUINE REDUCES THE BIOAVAILABILITY OF METHOTREXATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - A POSSIBLE MECHANISM OF REDUCED HEPATOTOXICITY
    SEIDEMAN, P
    ALBERTIONI, F
    BECK, O
    EKSBORG, S
    PETERSON, C
    ARTHRITIS AND RHEUMATISM, 1994, 37 (06): : 830 - 833
  • [8] A CLINICAL AND BIOCHEMICAL ASSESSMENT OF METHOTREXATE IN RHEUMATOID-ARTHRITIS
    TAIT, TJ
    LEGALLEZ, P
    ASTBURY, C
    BIRD, HA
    CLINICAL RHEUMATOLOGY, 1994, 13 (01) : 75 - 79
  • [9] SALICYLATE HEPATOTOXICITY IN PATIENTS WITH JUVENILE RHEUMATOID-ARTHRITIS
    RICH, RR
    JOHNSON, JS
    ARTHRITIS AND RHEUMATISM, 1973, 16 (01): : 1 - 9
  • [10] METHOTREXATE IN RHEUMATOID-ARTHRITIS
    WEINBLATT, ME
    KREMER, JM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (01) : 126 - 128